Follow
Gina Norato
Gina Norato
Verified email at nih.gov
Title
Cited by
Cited by
Year
Ischemic lesions, blood pressure dysregulation, and poor outcomes in intracerebral hemorrhage
CS Kidwell, J Rosand, G Norato, S Dixon, BB Worrall, ML James, ...
Neurology 88 (8), 782-788, 2017
842017
Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial
J Gold, DB Rowe, MC Kiernan, S Vucic, S Mathers, RPA van Eijk, A Nath, ...
Amyotrophic lateral sclerosis and frontotemporal degeneration 20 (7-8), 595-604, 2019
702019
Sensorimotor oscillatory phase–power interaction gates resting human corticospinal output
SJ Hussain, L Claudino, M Bönstrup, G Norato, G Cruciani, R Thompson, ...
Cerebral Cortex 29 (9), 3766-3777, 2019
622019
Effects of TPH2 gene variation and childhood trauma on the clinical and circuit-level phenotype of functional movement disorders
PA Spagnolo, G Norato, CW Maurer, D Goldman, C Hodgkinson, ...
Journal of Neurology, Neurosurgery & Psychiatry 91 (8), 814-821, 2020
472020
7T MRI differentiates remyelinated from demyelinated multiple sclerosis lesions
H Kolb, M Absinta, ES Beck, SK Ha, Y Song, G Norato, I Cortese, P Sati, ...
Annals of neurology 90 (4), 612-626, 2021
452021
Influence of lung function and sleep-disordered breathing on all-cause mortality. A community-based study
N Putcha, C Crainiceanu, G Norato, J Samet, SF Quan, DJ Gottlieb, ...
American journal of respiratory and critical care medicine 194 (8), 1007-1014, 2016
412016
fMRI prediction of naming change after adult temporal lobe epilepsy surgery: Activation matters
X You, AN Zachery, EJ Fanto, G Norato, SC Germeyan, EJ Emery, ...
Epilepsia 60 (3), 527-538, 2019
362019
Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy
M Garcia-Montojo, S Fathi, G Norato, BR Smith, DB Rowe, MC Kiernan, ...
Journal of the neurological sciences 423, 117358, 2021
342021
BK virus-specific T cells for immunotherapy of progressive multifocal leukoencephalopathy: an open-label, single-cohort pilot study
I Cortese, ES Beck, O Al-Louzi, J Ohayon, F Andrada, I Osuorah, J Dwyer, ...
The Lancet Neurology 20 (8), 639-652, 2021
332021
Longitudinal changes in clinical outcome measures in COL6-related dystrophies and LAMA2-related dystrophies
MS Jain, K Meilleur, E Kim, G Norato, M Waite, L Nelson, M McGuire, ...
Neurology 93 (21), e1932-e1943, 2019
282019
International retrospective natural history study of LMNA-related congenital muscular dystrophy
R Ben Yaou, P Yun, I Dabaj, G Norato, S Donkervoort, H Xiong, ...
Brain communications 3 (3), fcab075, 2021
232021
Language lateralization from task‐based and resting state functional MRI in patients with epilepsy
R Rolinski, X You, J Gonzalez‐Castillo, G Norato, RC Reynolds, SK Inati, ...
Human brain mapping 41 (11), 3133-3146, 2020
232020
Early change in stroke size performs best in predicting response to therapy
AN Simpkins, C Dias, G Norato, E Kim, R Leigh, ...
Cerebrovascular Diseases 44 (3-4), 141-149, 2017
232017
Respiratory magnetic resonance imaging biomarkers in Duchenne muscular dystrophy
A Mankodi, W Kovacs, G Norato, N Hsieh, WP Bandettini, CA Bishop, ...
Annals of clinical and translational neurology 4 (9), 655-662, 2017
212017
Giant axonal neuropathy: cross-sectional analysis of a large natural history cohort
DX Bharucha-Goebel, G Norato, D Saade, E Paredes, V Biancavilla, ...
Brain 144 (10), 3239-3250, 2021
152021
Phase-dependent offline enhancement of human motor memory
SJ Hussain, MK Vollmer, J Stimely, G Norato, C Zrenner, U Ziemann, ...
Brain stimulation 14 (4), 873-883, 2021
152021
Association of plasma biomarker levels with their CSF concentration and the number and severity of concussions in professional athletes
P Shahim, H Zetterberg, J Simrén, NJ Ashton, G Norato, M Schöll, ...
Neurology 99 (4), e347-e354, 2022
142022
Antibody response to HML‐2 may be protective in amyotrophic lateral sclerosis
M Garcia‐Montojo, ER Simula, S Fathi, C McMahan, A Ghosal, JD Berry, ...
Annals of Neurology 92 (5), 782-792, 2022
102022
A randomized controlled trial of SGS-742, a γ-aminobutyric acid B (GABA-B) receptor antagonist, for succinic semialdehyde dehydrogenase deficiency
JM Schreiber, E Wiggs, R Cuento, G Norato, IH Dustin, R Rolinski, ...
Journal of child neurology 36 (13-14), 1189-1199, 2021
102021
High rate of microbleed formation following primary intracerebral hemorrhage
J Mackey, JJ Wing, G Norato, I Sobotka, RS Menon, RE Burgess, ...
International Journal of Stroke 10 (8), 1187-1191, 2015
102015
The system can't perform the operation now. Try again later.
Articles 1–20